Target intelligence / Profile preview

Platelet-derived growth factor (PDGF) (PDGF)

Target
PDGF
Molecular classification
Growth factor, Cytokine
01

Overview

Platelet-derived growth factor (PDGF) is a family of dimeric glycoproteins that serve as potent mitogens for cells of mesenchymal origin, including fibroblasts and smooth muscle cells. It plays a fundamental role in physiological processes such as embryonic development, angiogenesis, and wound healing by stimulating cell proliferation and chemotaxis (Source: StatPearls). In the clinical context of autologous platelet-rich plasma (PRP), PDGF is a major bioactive component released from platelet alpha-granules that drives tissue repair and regeneration (Source: NIH). However, overactive PDGF signaling is implicated in various diseases, including atherosclerosis, pulmonary fibrosis, and the growth of several types of cancer, such as glioblastoma and dermatofibrosarcoma protuberans (Source: Nature Reviews Cancer). Therapeutic strategies involve either the application of recombinant PDGF (e.g., Becaplermin) to accelerate the healing of chronic diabetic foot ulcers or the use of tyrosine kinase inhibitors (e.g., Imatinib, Sunitinib) to block PDGF receptor signaling in malignant and fibrotic conditions (Source: PubChem).

Other names
PDGFPlatelet-derived growth factor subunit APlatelet-derived growth factor subunit BGlioma-derived growth factorPDGF-AAPDGF-BBPDGF-AB
02

Mechanism of action

PDGF ligands bind to and activate Platelet-derived growth factor receptors (PDGFR-alpha and PDGFR-beta), which are receptor tyrosine kinases. This binding induces receptor dimerization and autophosphorylation, initiating downstream signaling pathways such as PI3K/Akt, Ras/MAPK, and PLC-gamma that regulate cell growth, division, and migration (Source: UniProt; StatPearls).

03

Biological functions

Signal transductionCell proliferationWound healingAngiogenesisMitogenesisChemotaxis
04

Disease associations

CancerFibrosisAtherosclerosisChronic woundsPulmonary hypertension
05

Safety considerations

Increased risk of malignancy with prolonged topical use of recombinant PDGF (Becaplermin)Cardiovascular toxicity associated with receptor tyrosine kinase inhibitorsImpaired wound healingFluid retention and edemaPotential for excessive fibrosis in non-target tissues
06

Interacting drugs

Becaplermin

6 more in the full profile.

07

Biomarkers

PDGF-BB concentrationPDGFR-alpha expressionPDGFR-beta expressionPDGFRA gene amplification

Beyond the preview

Go deeper on Platelet-derived growth factor (PDGF) (PDGF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Platelet-derived growth factor (PDGF) (PDGF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call